UPDATE : Wednesday, January 22, 2020
Celltrion 1st Korean biopharmaceutical firm to achieve $1-billion exports by Lee Han-soo 2019-12-05 15:04
Macrogen’s research on Asian genomic database becomes cover story of Nature by Lee Han-soo 2019-12-05 11:54
‘Obesity treatment will drastically change next few years’ by Lee Han-soo 2019-12-04 18:20
'Insulin is safe, natural replacement therapy for diabetic patients' by Lee Han-soo 2019-12-04 17:07
Hanmi licenses in US firm’s oral immunotherapy candidate by Lee Han-soo 2019-12-04 16:16
ISU Abxis starts trial of Gaucher disease treatment in Australia by Lee Han-soo 2019-12-04 16:16
Swedish researchers divide Type 2 diabetes into 5 subgroups by Lee Han-soo 2019-12-03 17:45
Ildong signs co-promotion contract with GSK Consumer Healthcare by Lee Han-soo 2019-12-03 15:18
Global diabetes group opens 5-day show in Busan by Lee Han-soo 2019-12-03 11:04
‘Obesity needs to be treated as a chronic disease’ by Lee Han-soo 2019-12-02 18:02
AMC develop treatment guideline lowering rectal cancer’s recurrence rate by Lee Han-soo 2019-12-02 16:46
LG Chem licenses in US firm’s diagnostic platform tech by Lee Han-soo 2019-12-02 13:42
Syntekabio views industry’s crisis as opportunity by Jeong Sae-im 2019-11-29 17:54
S. Biomedics to test embryonic stem cell-derived spinal cord injury treatment by Lee Han-soo 2019-11-29 15:42
GC MS wins US patent for influenza diagnostic technology by Lee Han-soo 2019-11-29 12:18
Hanmi's Chinese partner to start trials for anticancer treatment by Lee Han-soo 2019-11-28 17:38
GI Innovation licenses out immunotherapy drug candidate to Chinese firm by Lee Han-soo 2019-11-28 16:26
Takeda's ovarian cancer drug Zejula to get insurance benefit by Lee Han-soo 2019-11-28 15:36
ST Pharm submits IND application for colorectal cancer treatment in US by Lee Han-soo 2019-11-28 14:52
Experts ascribe excessive diabetes hospitalization to lack of early treatment by Lee Han-soo 2019-11-28 11:26
Back to Top